168 related articles for article (PubMed ID: 36989543)
1. TREM2: A new player in the tumor microenvironment.
Molgora M; Liu YA; Colonna M; Cella M
Semin Immunol; 2023 May; 67():101739. PubMed ID: 36989543
[TBL] [Abstract][Full Text] [Related]
2. TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy.
Molgora M; Esaulova E; Vermi W; Hou J; Chen Y; Luo J; Brioschi S; Bugatti M; Omodei AS; Ricci B; Fronick C; Panda SK; Takeuchi Y; Gubin MM; Faccio R; Cella M; Gilfillan S; Unanue ER; Artyomov MN; Schreiber RD; Colonna M
Cell; 2020 Aug; 182(4):886-900.e17. PubMed ID: 32783918
[TBL] [Abstract][Full Text] [Related]
3. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
Peshoff MM; Gupta P; Oberai S; Trivedi R; Katayama H; Chakrapani P; Dang M; Migliozzi S; Gumin J; Kadri DB; Lin JK; Milam NK; Maynard ME; Vaillant BD; Parker-Kerrigan B; Lang FF; Huse JT; Iavarone A; Wang L; Clise-Dwyer K; Bhat KP
Neuro Oncol; 2024 May; 26(5):826-839. PubMed ID: 38237157
[TBL] [Abstract][Full Text] [Related]
4. TREM2 knockdown improves the therapeutic effect of PD-1 blockade in hepatocellular carcinoma.
Wang Q; Zheng K; Tan D; Liang G
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):140-146. PubMed ID: 36332476
[TBL] [Abstract][Full Text] [Related]
5. TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma.
Sun R; Han R; McCornack C; Khan S; Tabor GT; Chen Y; Hou J; Jiang H; Schoch KM; Mao DD; Cleary R; Yang A; Liu Q; Luo J; Petti A; Miller TM; Ulrich JD; Holtzman DM; Kim AH
Sci Adv; 2023 May; 9(19):eade3559. PubMed ID: 37172094
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Impact of TREM2 in Tumor-Associated Macrophages.
Khantakova D; Brioschi S; Molgora M
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746551
[TBL] [Abstract][Full Text] [Related]
7.
Yu M; Chang Y; Zhai Y; Pang B; Wang P; Li G; Jiang T; Zeng F
Front Immunol; 2022; 13():1089266. PubMed ID: 36713360
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis Highlights the Immunosuppressive Role of TREM2
Zhou L; Wang M; Guo H; Hou J; Zhang Y; Li M; Wu X; Chen X; Wang L
Front Immunol; 2022; 13():848367. PubMed ID: 35359989
[TBL] [Abstract][Full Text] [Related]
9. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
10. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke.
Hu M; Lin Y; Men X; Wang S; Sun X; Zhu Q; Lu D; Liu S; Zhang B; Cai W; Lu Z
J Neuroinflammation; 2021 Apr; 18(1):90. PubMed ID: 33845849
[TBL] [Abstract][Full Text] [Related]
11. Microglial response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice after systemic stimulation with Escherichia coli.
Hoogland ICM; Yik J; Westhoff D; Engelen-Lee JY; Valls Seron M; Man WK; Houben-Weerts JHPM; Tanck MW; van Westerloo DJ; van der Poll T; van Gool WA; van de Beek D
Neurosci Lett; 2022 Nov; 790():136894. PubMed ID: 36183964
[TBL] [Abstract][Full Text] [Related]
12. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.
Jay TR; Miller CM; Cheng PJ; Graham LC; Bemiller S; Broihier ML; Xu G; Margevicius D; Karlo JC; Sousa GL; Cotleur AC; Butovsky O; Bekris L; Staugaitis SM; Leverenz JB; Pimplikar SW; Landreth GE; Howell GR; Ransohoff RM; Lamb BT
J Exp Med; 2015 Mar; 212(3):287-95. PubMed ID: 25732305
[TBL] [Abstract][Full Text] [Related]
13. TREM2 has a significant, gender-specific, effect on human obesity.
Reich T; Adato O; Kofman NS; Feiglin A; Unger R
Sci Rep; 2023 Jan; 13(1):482. PubMed ID: 36627355
[TBL] [Abstract][Full Text] [Related]
14. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
[TBL] [Abstract][Full Text] [Related]
15. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer.
Park MD; Reyes-Torres I; LeBerichel J; Hamon P; LaMarche NM; Hegde S; Belabed M; Troncoso L; Grout JA; Magen A; Humblin E; Nair A; Molgora M; Hou J; Newman JH; Farkas AM; Leader AM; Dawson T; D'Souza D; Hamel S; Sanchez-Paulete AR; Maier B; Bhardwaj N; Martin JC; Kamphorst AO; Kenigsberg E; Casanova-Acebes M; Horowitz A; Brown BD; De Andrade LF; Colonna M; Marron TU; Merad M
Nat Immunol; 2023 May; 24(5):792-801. PubMed ID: 37081148
[TBL] [Abstract][Full Text] [Related]
16. Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) positively regulates lipopolysaccharide-induced expression of CXC chemokine ligand 10 and 11 in mouse macrophages.
Bandow K; Smith A; Garlick J
Biochem Biophys Res Commun; 2022 Dec; 635():227-235. PubMed ID: 36283335
[TBL] [Abstract][Full Text] [Related]
17. TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy.
Qiu H; Shao Z; Wen X; Jiang J; Ma Q; Wang Y; Huang L; Ding X; Zhang L
Front Immunol; 2021; 12():716710. PubMed ID: 34539652
[TBL] [Abstract][Full Text] [Related]
18. Soluble TREM2 levels reflect the recruitment and expansion of TREM2
Hendrikx T; Porsch F; Kiss MG; Rajcic D; Papac-Miličević N; Hoebinger C; Goederle L; Hladik A; Shaw LE; Horstmann H; Knapp S; Derdak S; Bilban M; Heintz L; Krawczyk M; Paternostro R; Trauner M; Farlik M; Wolf D; Binder CJ
J Hepatol; 2022 Nov; 77(5):1373-1385. PubMed ID: 35750138
[TBL] [Abstract][Full Text] [Related]
19. TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas.
Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Bosco DB; Huang T; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Qi F; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
Neuro Oncol; 2024 May; 26(5):811-825. PubMed ID: 37941134
[TBL] [Abstract][Full Text] [Related]
20. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
